| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Alterations of a spectrum of driver genes in female Chinese patients with advanced or metastatic squamous cell carcinoma of the lung
|
Qiong, Zhao
|
|
2015
|
87 |
2 |
p. 117-121
5 p.
|
artikel
|
| 2 |
A phase II study of cisplatin plus S-1 with concurrent thoracic radiotherapy for locally advanced non-small-cell lung cancer: The Okayama Lung Cancer Study Group Trial 0501
|
Nogami, Naoyuki
|
|
2015
|
87 |
2 |
p. 141-147
7 p.
|
artikel
|
| 3 |
A phase 2 study of bevacizumab in combination with carboplatin and paclitaxel in patients with non-squamous non-small-cell lung cancer harboring mutations of epidermal growth factor receptor (EGFR) after failing first-line EGFR-tyrosine kinase inhibitors (HANSHIN Oncology Group 0109)
|
Hattori, Yoshihiro
|
|
2015
|
87 |
2 |
p. 136-140
5 p.
|
artikel
|
| 4 |
Choroidal metastasis response to crizotinib in a ROS1-rearranged NSCLC patient
|
Lu, Stephanie
|
|
2015
|
87 |
2 |
p. 207-209
3 p.
|
artikel
|
| 5 |
Contents
|
|
|
2015
|
87 |
2 |
p. v-vi
nvt p.
|
artikel
|
| 6 |
Corrigendum to “Randomized open-label non-comparative multicenter phase II trial of sequential erlotinib and docetaxel versus docetaxel alone in patients with non-small-cell lung cancer after failure of first-line chemotherapy: GFPC 10.02 study” [Lung Cancer 85 (2014) 415–419]
|
Auliac, J.B.
|
|
2015
|
87 |
2 |
p. 210-
1 p.
|
artikel
|
| 7 |
Different clinical effects upon separate inhibition of coexisting EGFR and PI3KCA mutations in a lung adenocarcinoma patient
|
Tiseo, Marcello
|
|
2015
|
87 |
2 |
p. 204-206
3 p.
|
artikel
|
| 8 |
Editorial Board
|
|
|
2015
|
87 |
2 |
p. iii-
1 p.
|
artikel
|
| 9 |
Efficacy of EGFR tyrosine kinase inhibitors in patients with EGFR-mutated non-small cell lung cancer except both exon 19 deletion and exon 21 L858R: A retrospective analysis in Korea
|
Baek, Jin Ho
|
|
2015
|
87 |
2 |
p. 148-154
7 p.
|
artikel
|
| 10 |
Genetic variants in genes of tricarboxylic acid cycle key enzymes are associated with prognosis of patients with non-small cell lung cancer
|
Guo, Xu
|
|
2015
|
87 |
2 |
p. 162-168
7 p.
|
artikel
|
| 11 |
Hypoxia-induced cell stemness leads to drug resistance and poor prognosis in lung adenocarcinoma
|
Zhao, Mingchuan
|
|
2015
|
87 |
2 |
p. 98-106
9 p.
|
artikel
|
| 12 |
Increased expression of 17-beta-hydroxysteroid dehydrogenase type 1 in non-small cell lung cancer
|
Drzewiecka, Hanna
|
|
2015
|
87 |
2 |
p. 107-116
10 p.
|
artikel
|
| 13 |
Is fourth-line chemotherapy routine practice in advanced non-small cell lung cancer?
|
Choi, Yong Won
|
|
2015
|
87 |
2 |
p. 155-161
7 p.
|
artikel
|
| 14 |
Longitudinal analysis of 2293 NSCLC patients: A comprehensive study from the TYROL registry
|
Kocher, Florian
|
|
2015
|
87 |
2 |
p. 193-200
8 p.
|
artikel
|
| 15 |
Management of crizotinib therapy for ALK-rearranged non-small cell lung carcinoma: An expert consensus
|
Cappuzzo, Federico
|
|
2015
|
87 |
2 |
p. 89-95
7 p.
|
artikel
|
| 16 |
Palliative thoracic radiotherapy for patients with advanced non-small cell lung cancer and poor performance status
|
Walasek, Tomasz
|
|
2015
|
87 |
2 |
p. 130-135
6 p.
|
artikel
|
| 17 |
Parallel screening for ALK, MET and ROS1 alterations in non-small cell lung cancer with implications for daily routine testing
|
Jurmeister, Philipp
|
|
2015
|
87 |
2 |
p. 122-129
8 p.
|
artikel
|
| 18 |
Quantification and consequences of lung cancer CT overdiagnosis
|
Reich, Jerome M.
|
|
2015
|
87 |
2 |
p. 96-97
2 p.
|
artikel
|
| 19 |
Real-world treatment patterns and costs in a US Medicare population with metastatic squamous non-small cell lung cancer
|
Davis, Keith L.
|
|
2015
|
87 |
2 |
p. 176-185
10 p.
|
artikel
|
| 20 |
The impact of common and rare EGFR mutations in response to EGFR tyrosine kinase inhibitors and platinum-based chemotherapy in patients with non-small cell lung cancer
|
Arrieta, Oscar
|
|
2015
|
87 |
2 |
p. 169-175
7 p.
|
artikel
|
| 21 |
The impact of comorbidity upon determinants of outcome in patients with lung cancer
|
Grose, Derek
|
|
2015
|
87 |
2 |
p. 186-192
7 p.
|
artikel
|
| 22 |
Tumor flare after start of RAF inhibition in KRAS mutated NSCLC: A case report
|
Mellema, Wouter W.
|
|
2015
|
87 |
2 |
p. 201-203
3 p.
|
artikel
|
Tijdschrift beschrijving